Ganoderma lucidum (‘Lingzhi’); acute and short-term biomarker response to supplementation
暂无分享,去创建一个
[1] M. Manzoni,et al. Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs , 2002, Applied Microbiology and Biotechnology.
[2] I. Benzie,et al. Effects of Dietary Antioxidants on Human DNA Ex Vivo , 2002, Free radical research.
[3] B. Tomlinson,et al. Total antioxidant and ascorbic acid content of fresh fruits and vegetables: implications for dietary planning and food preservation , 2002, British Journal of Nutrition.
[4] Y. Surh,et al. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum , 2001, Phytotherapy research : PTR.
[5] Robert Luben,et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study , 2001, The Lancet.
[6] M. Traber. Does vitamin E decrease heart attack risk? summary and implications with respect to dietary recommendations. , 2001, The Journal of nutrition.
[7] F Santeusanio,et al. Relation Between Serum Uric Acid and Risk of Cardiovascular Disease in Essential Hypertension: The PIUMA Study , 2000, Hypertension.
[8] N. Nakamura,et al. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. , 2000, Chemical & pharmaceutical bulletin.
[9] S. Chiu,et al. Nutritional value of ganoderma extract and assessment of its genotoxicity and antigenotoxicity using comet assays of mouse lymphocytes. , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[10] Ronald C. Li,et al. Triterpene antioxidants from Ganoderma lucidum , 1999, Phytotherapy research : PTR.
[11] S. Kacew,et al. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). , 1999, Carcinogenesis.
[12] I. Benzie,et al. Total antioxidant capacity of teas by the ferric reducing/antioxidant power assay. , 1999, Journal of agricultural and food chemistry.
[13] W. Frishman,et al. Herbal medicine for the treatment of cardiovascular disease: clinical considerations. , 1998, Archives of internal medicine.
[14] J. Strain,et al. Simultaneous automated measurement of total 'antioxidant' (reducing) capacity and ascorbic acid concentration. , 1997, Redox report : communications in free radical research.
[15] C. Ho,et al. The anti‐tumor effect of Ganoderma Lucidum is mediated by cytokines released from activated macrophages and T lymphocytes , 1997, International journal of cancer.
[16] J. Strain,et al. Uric acid: friend or foe? , 1996, Redox report : communications in free radical research.
[17] J J Strain,et al. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. , 1996, Analytical biochemistry.
[18] W. Riley,et al. Evaluation of Serum and Tissue Levels of α-Tocopherol , 1996 .
[19] T. Byers,et al. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study. , 1995, American journal of epidemiology.
[20] T. Mizuno,et al. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects , 1995 .
[21] M. Shiao,et al. Natural Products and Biological Activities of the Chinese Medicinal Fungus Ganoderma lucidum , 1994 .
[22] S. Furusawa,et al. Antitumour activity of Ganoderma lucidum, an edible mushroom, on intraperitoneally implanted lewis lung carcinoma in synergenic mice , 1992 .
[23] K. Jones,et al. Reishi Mushroom: Herb of Spiritual Potency and Medical Wonder , 1990 .
[24] H. Rhee,et al. Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. , 1990, Chemical & pharmaceutical bulletin.
[25] M. Shimizu,et al. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. , 1989, Chemical & pharmaceutical bulletin.
[26] R. D. Situnayake,et al. The Use of Different Lipids to Express Serum Tocopherol: Lipid Ratios for the Measurement of Vitamin E Status , 1986, Annals of clinical biochemistry.
[27] M. Lopes-Virella,et al. Cholesterol determination in high-density lipoproteins separated by three different methods. , 1977, Clinical chemistry.
[28] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[29] A. Osbourn,et al. Biosynthesis of triterpenoid saponins in plants. , 2002, Advances in biochemical engineering/biotechnology.
[30] B. Tomlinson,et al. Consumption of green tea causes rapid increase in plasma antioxidant power in humans. , 1999, Nutrition and cancer.
[31] J. Strain,et al. Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. , 1999, Methods in enzymology.
[32] Solomon P. Wasser,et al. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspectives (review). , 1999 .
[33] J. Buswell,et al. Ganoderma lucidum (Curt.: Fr.) P. Karst. (Aphyllophoromycetideae)−A Mushrooming Medicinal Mushroom , 1999 .
[34] M. Dusinska,et al. Comet assay in human biomonitoring studies: Reliability, validation, and applications , 1997, Environmental and molecular mutagenesis.
[35] P. Fürst,et al. Improved analysis of malondialdehyde in human body fluids. , 1996, Free radical biology & medicine.
[36] B. Halliwell,et al. Lipid peroxidation in hyperlipidaemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. , 1993, Free radical research communications.
[37] S C Jong,et al. Medicinal benefits of the mushroom Ganoderma. , 1992, Advances in applied microbiology.